Affymetrix, Santa Clara, California 95051, USA
1 Corresponding author.
E-MAIL: dione_kampa@affymetrix.com
; FAX (408) 481-0422.
In this report, we have achieved a richer view of the transcriptome for Chromosomes 21 and 22 by using high-density oligonucleotide arrays on cytosolic polyA+ RNA. Conservatively, only 31.4% of the observed transcribed nucleotides correspond to well-annotated genes, whereas an additional 4.8% and 14.7% correspond to mRNAs and ESTs, respectively. Approximately 85% of the known exons were detected, and up to 21% of known genes have only a single isoform based on exon-skipping alternative expression. Overall, the expression of the well-characterized exons falls predominately into two categories, uniquely or ubiquitously expressed with an identifiable proportion of antisense transcripts. The remaining observed transcription (49.0%) was outside of any known annotation. These novel transcripts appear to be more cell-line-specific and have lower and less variation in expression than the well-characterized genes. Novel transcripts were further characterized based on their distance to annotations, transcript size, coding capacity, and identification as antisense to intronic sequences. By RT-PCR, 126 novel transcripts were independently verified, resulting in a 65% verification rate. These observations strongly support the argument for a re-evaluation of the total number of human genes and an alternative term for "gene" to encompass these growing, novel classes of RNA transcripts in the human genome.
Cawley S, Bekiranov S, Ng HH, Kapranov P, Sekinger EA, Kampa D, Piccolboni A, Sementchenko V, Cheng J, Williams AJ, Wheeler R, Wong B, Drenkow J, Yamanaka M, Patel S, Brubaker S, Tammana H, Helt G, Struhl K, and Gingeras TR, "Unbiased Mapping of Transcription Factor Binding Sites along Human Chromosomes 21 and 22 Points to Widespread Regulation of Noncoding RNAs".
1. Prasanth KV, Sacco-Bubulya PA, Prasanth SG, and Spector DL, "Sequential Entry of Components of Gene Expression Machinery into Daughter Nuclei", Mol. Biol. Cell, 14: 1043 (2003).
2. Frenster JH, and Hovsepian JA, "Overshoot in Late Telophase for RNA Re-Programming of Mitotic Chromatin", RNA 2003, 211 (2003).
3. Frenster JH, "Yeast RNA Re-Programming of Already-Active Mammalian Chromatin". RNA 2002, 592 (2002).
4. Frenster JH, "Activation of DNA Transcription within Repressed Chromatin by Nuclear RNA Species", RNA 2001, 237 (2001).
5. Hovsepian JA, and Frenster JH, "RNA-Induced Melting of DNA during
Selective Gene Transcription",
Molec. Biol.
Cell, vol. 13, supp. p. 239a (November, 2002).
1. Byrne JA, Simonsson S, Western PS, and Gurdon JB, "Nuclei of Adult Mammalian Somatic Cells are Directly Reprogrammed to oct-4 Stem Cell Gene Expression by Amphibian Oocytes", Current Biology, vol 13, no. 14, pp. 1206-1213 (July 15, 2003).
2. Li L, Connelly MC, Wetmore C, Curran T, and Morgan JI, "Mouse Embryos Cloned from Brain Tumors", Cancer Research vol. 63, no. 11, pp. 2733-2736 (June 1, 2003).
3. Goldstein L, “Stable Nuclear RNA Returns to Post-Division Nuclei Following Release to Cytoplasm during Mitosis”, Exp. Cell Res. vol. 89, no. 2, pp. 421-425 (December, 1974).
4. Geiss G, Jin G, Guo J, Bumgarner R, Katze MG, and Sen GC, "A Comprehensive View of Regulation of Gene Expression by Double-Stranded RNA-Mediated Cell Signaling", J. Biol. Chem. vol. 276, pp. 30178-30182 (2001).
5. Persengiev SP, Zhu X and Green MR, "Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs)", RNA, vol. 10, no. 1, pp. 12-18 (January, 2004).
6. Gottesfeld JM, and Barbas III CF, "RNA as a Transcriptional
Activator", Chemistry
and Biology, vol 10, no.7, pp. 584-585 (July, 2003).
Reviews and Research:
Links to
Euchromatin Activator RNA Reviews:
Links to
Euchromatin Activator RNA Research:
Links to Ultrastructural
Probes of DNase I-Sensitive Sites:
Links to
RNA as a Therapeutic Agent:
Links to Hodgkin Lymphoma
Immuno-Pathology:
Links to Activated
T-Lymphocyte Immunotherapy:
Links to Medical
Systems Biology:
"Ultrastructural Probes of Active DNA Sites, and the RNA Activators of DNA".
For Further Information and Feedback:
E-mail: frenster@euchromatin.net